Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 17Breast Neoplasms 14Rectal Neoplasms 13Nasopharyngeal Carcinoma 8Stomach Neoplasms 5Triple Negative Breast Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Biliary Tract Neoplasms 3Adenocarcinoma 3Recurrence 2Pancreatic Neoplasms 2HER2-positive Gastric Cancer 2Carcinoma, Non-Small-Cell Lung 2Spinocerebellar Degenerations 1Rectal Neoplasms Malignant 1Rectal Cancer Patients 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Pancreatic Cancer Non-resectable 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Metastatic Breast Cancer in the Brain 1MSI-H Colorectal Cancer 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Rectal Cancer 1

Interventions

Immune Checkpoint Inhibitors 2sintilimab 1Oxaliplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Spinocerebellar Degenerations × Capecitabine × Clear all
NCT07551479 2026-04-24

TORCH-STAR

Fudan University

Phase 3 Not yet recruiting
612 enrolled

Spinocerebellar Degenerations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡